INCREASED [H-3] NITRENDIPINE BINDING-SITES IN RAT-HEART DURING ADULT MATURATION AND AGING

被引:9
|
作者
NAVARATNAM, S
KHATTER, JC
机构
[1] UNIV MANITOBA,DEPT INTERNAL MED,WINNIPEG R3T 2N2,MANITOBA,CANADA
[2] UNIV MANITOBA,DEPT PHARMACOL,WINNIPEG R3T 2N2,MANITOBA,CANADA
关键词
D O I
10.1016/0006-2952(91)90632-F
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To study the effects of maturation and aging on calcium channels, we investigated the characteristics of binding of a radioligand, [H-3]nitrendipine, to relatively pure sarcolemmal membranes from 2-, 12- and 24-month-old Sprague-Dawley rat hearts. Specific binding of [H-3]nitrendipine was saturable, and the Scatchard analysis of the binding revealed a single class of binding sites. Binding of [H-3]nitrendipine to the membrane of 12-month-old-rats was 50-75% greater than to the membrane of 2-month-old young adult rats with no further changes in binding during aging from 12 to 24 months. The maximum number of dihydropyridine binding sites (B(max)) was 70% higher in 12- and 24-month-old rat hearts (0.45 and 0.43 pmol/mg protein) than in 2-month-old rats (0.27 pmol/mg protein). The affinity for [H-3]nitrendipine binding, on the other hand, was similar in all three age groups (K(D) values of 0.27, 0.31 and 0.29 nM in 2-, 12- and 24-month-old rats, respectively, at 25-degrees). Membranes of all three age groups showed a similar degree of enrichment in sarcolemmal marker enzymes, indicating that the difference in membrane purity was not a contributing factor to the observed increase in density. Furthermore, increased binding of [H-3]nitrendipine to the membranes of older rat hearts was observed throughout the purification scheme. Since [H-3]nitrendipine binding sites are considered to be specific sites for voltage-gated Ca2+ channels of the sarcolemma, it is concluded that the density of these channels in the myocardium increases during adult maturation and is maintained through senescence.
引用
收藏
页码:593 / 600
页数:8
相关论文
共 50 条
  • [21] THE MULTIPLE BINDING-SITES OF H-3 PCP AND H-3 TCP IN THE RAT AND THE HUMAN CNS
    CHICHEPORTICHE, R
    AGID, RY
    CHAUDIEU, I
    FINIELS, F
    GUIRAMAND, J
    JAVOYAGID, F
    JOURNOT, L
    KAMENKA, JM
    PRIVAT, A
    VIGNON, J
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 28 (01) : 119 - 120
  • [22] REGIONAL AND SUBCELLULAR-DISTRIBUTION OF [H-3]NITRENDIPINE BINDING-SITES IN SHR AND WKY RATS
    ROSS, D
    MONIS, N
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 12 : S94 - S97
  • [23] INVIVO IDENTIFICATION OF CALCIUM-ANTAGONIST BINDING-SITES USING [H-3]-LABELED NITRENDIPINE
    SCHOEMAKER, H
    LEE, HR
    ROESKE, WR
    YAMAMURA, HI
    FEDERATION PROCEEDINGS, 1983, 42 (04) : 843 - 843
  • [24] MELATONIN REDUCES H-3 NITRENDIPINE BINDING IN THE HEART
    CHEN, LD
    KUMAR, P
    REITER, RJ
    TAN, DX
    CHAMBER, JP
    MANCHESTER, LC
    POEGGELER, B
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1994, 207 (01): : 34 - 37
  • [25] BINDING OF [H-3] NITRENDIPINE AND [H-3] DILTIAZEM TO RAT MYOCARDIAL SARCOLEMMA
    MIWA, N
    KANAIDE, H
    NISHIMURA, J
    NAKAMURA, M
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1986, 36-2 (07): : 1059 - 1062
  • [26] CHRONIC MORPHINE TREATMENT INCREASES THE NUMBER, BUT DECREASES THE AFFINITY OF [H-3] U69,593 BINDING-SITES IN THE RAT-HEART
    XIA, Q
    TAI, KK
    WONG, TM
    LIFE SCIENCES, 1992, 50 (16) : 1143 - 1148
  • [27] THE CHARACTERIZATION OF [H-3] SULPIRIDE BINDING-SITES IN RAT STRIATAL MEMBRANES
    IMAFUKU, J
    BRAIN RESEARCH, 1987, 402 (02) : 331 - 338
  • [28] SOLUBILIZATION OF NOVEL BINDING-SITES FOR [H-3] GLUTAMATE IN RAT ADRENAL
    YONEDA, Y
    OGITA, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 142 (02) : 609 - 616
  • [29] H-3 DOMPERIDONE BINDING-SITES DIFFER IN RAT STRIATUM AND PITUITARY
    SOKOLOFF, P
    MARTRES, MP
    DELANDRE, M
    REDOUANE, K
    SCHWARTZ, JC
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1984, 327 (03) : 221 - 227
  • [30] [H-3] GLUTAMATE BINDING-SITES SOLUBILIZED FROM RAT ADRENAL
    YONEDA, Y
    OGITA, K
    OGAWA, Y
    JAPANESE JOURNAL OF PHARMACOLOGY, 1987, 43 : P111 - P111